Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Bone and Soft Tissue Pathology for the Surgical Pathologist

Harvard Medical School, Department of Continuing Education
Bone and Soft Tissue Pathology for the Surgical Pathologist provides a comprehensive review of selected topics in bone and soft tissue pathology. The faculty is comprised of leaders in the field who give their perspective on a variety of subjects ranging from growth and development of the skeletal system to an organized review of common and unusual tumors and tumor-like lesions of the musculoskeletal system.
 
CREDITS Earn up to 11.25 AMA PRA Category 1 Credit(s)™.
CE RELEASE December 1, 2008
CE EXPIRE December 1, 2010
 
Item No Media (Can't decide on a format?) Price Purchase
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Jack O´ Toole at 1-800-952-0690 x3034. For all other sales inquiries, call 1-800-633-4743.
 

Topics & Speakers


  • Walter J. Putschar Lecture: Problems of
    Prognostication in Soft Tissue Tumors
  • Walter J. Putschar Lecture: The Differential
    Diagnosis of Myxoid Soft Tissue Tumors

    Christopher D.M. Fletcher, MD
  • Rhabdomyosarcoma: Current Morphologic and
    Molecular Classification

    Antonio R. Perez-Atayde, MD
  • Skeletal System - From Conception to Puberty
    Alan L. Schiller, MD
  • Osteoblasts and Osteoclasts: Friends and Foes
  • Differential Diagnosis of Matrix Forming Tumors—
    Bone Forming Neoplasms
  • Small Round Cell Tumors of Bone
  • Pseudosarcomas of Soft Tissue
    Andrew E. Rosenberg, MD
  • Differential Diagnosis of Matrix Forming Tumors—
    Cartilage Forming Neoplasms
  • Diseases of the Synovium
    G. Petur Nielsen, MD
  • Soft Tissue Tumors of the Lower Genital Tract
    Marisa R. Nucci, MD
  • Update on Peripheral Nerve Tumors
    Briana C. Gleason, MD
  • New Entities in Soft Tissue Pathology
    Alessandra F. Nascimento, MD
  • Practical Applications of Molecular Diagnostics in
    Bone and Soft Tissue Tumors

    Jonathan A. Fletcher, MD
  • Cytogenetics of Bone and Soft Tissue Tumors
    Paola Dal Cin, PhD
  • Myoepithelial Tumors and Their Mimics
    Jason L. Hornick, MD, PhD

Course Directors

Andrew E. Rosenberg, MD
Associate Professor of Pathology

Christopher D.M. Fletcher, MD
Professor of Pathology

 

Harvard Faculty

 

Paola Dal Cin, PhD
Associate Professor of Pathology

Jonathan A. Fletcher, MD
Associate Professor of Pathology
Associate Professor of Pediatrics

Briana C. Gleason, MD
Instructor in Pathology

Jason L. Hornick, MD, PhD
Assistant Professor in Pathology

Alessandra F. Nascimento, MD
Assistant Professor in Pathology

G. Petur Nielsen, MD
Associate Professor of Pathology

Marisa R. Nucci, MD
Associate Professor of Pathology

Antonio R. Perez-Atayde, MD
Associate Professor of Pathology

Guest Faculty

Alan L. Schiller, MD
Irene Heinz and John LaPorte Given Professor
Chairman of the Department of Pathology
Mount Sinai School of Medicine
New York City, NY

 

 
 

Learning Objectives


After viewing this activity, participants will be able to:
  • Understand the process of growth and development of the skeletal system and the organic and inorganic components of which it is comprised
  • Increase knowledge of the diagnostic criteria of a variety of primary bone tumors
  • Increase knowledge of the diagnostic criteria of a variety of primary soft tissue tumors and tumor-like processes
  • Understand the role of molecular biology and cytogenetics in the diagnosis of bone and soft tissue tumors

 
 

Accreditation Statement


Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
 

Designation


Harvard Medical School designates this educational activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release date: December 1, 2008. Credits expire: December 1, 2010.

CME credit is obtained upon successful completion of an activity post-test, as well as payment of a $30 processing fee.


 
 

Disclosure Statement


Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. Now, in accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers and their spouses/partners, and planners have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prosthesis, etc. that might be germane to the content of their lectures. Please note that now in accordance with recent policies from the ACCME, relationships of the person involved in the CME activity must include financial relationships of a spouse or partner.

In addition, faculty have been asked to describe any off label uses, they will discuss, of pharmaceuticals and devices for investigational or non-FDA approved purposes.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk. The full disclosure of faculty is listed in the syllabus.